Clinical Trial Update: A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil [Phase 1]

View source ↗

Summary

A Phase 1 bridging study of Efsubaglutide Alfa in healthy adults in Brazil is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Efsubaglutide Alfa (efsubaglutide alfa)

Snippet

Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | Conditions: Diabete Type 2 | Phase 1 | Status: NOT_YET_RECRUITING